The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

Medtronic is a large medical device company with a strong history of returning value to shareholders. It has a 3.25% dividend yield and an attractive valuation. Medtronic is taking important steps ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity (New Diabetes Company).

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit ...

Learn how to tie a crawler harness for walleye fishing using basic components like fluorocarbon line, octopus hooks, beads, and spinners. Step-by-step DIY guide ...

Medtronic to spin off diabetes business, form new company The separation is expected to be completed in 18 months.

Medical-device maker Medtronic MDT -0.13% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Medtronic said Wednesday it plans to separate its diabetes business, which generates more than $2.8 billion in annual sales, into a new publicly traded company.

Medtronic’s diabetes section to become separate company Medtronic says it now plans to separate its diabetes business from other operations and create a new company.